A method for producing heterocyclic acid anhydrides and pyrimidinediones from the corresponding acids, dicarboxamides, 2,3-and 3,4-pyridinedicarboxamides, and N-monosubstituted 2,3-and 3,4-pyridinedicarboxamides, in which the aforesaid compounds are reacted with lead tetra-acetate in the presence of a suitable anhydrous inert solvent.
QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS
申请人:Gilead Sciences, Inc.
公开号:US20220119383A1
公开(公告)日:2022-04-21
The present disclosure provides a compound of Formula (I):
or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.